For people without diabetes, continuous glucose monitors may not accurately reflect blood sugar control
Post Details (Top)
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
Continuous glucose monitors (CGMs) are wearable technologies that track blood sugar in real time and help patients with type 2 diabetes improve blood sugar control. In 2024, the U.S. Food and Drug Administration approved over-the-counter CGMs for individuals with and without diabetes, but there is limited understanding of how to interpret CGM metrics in individuals who do not have diabetes.
In-Article-1
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
In-Article-2 Desktop Banner (This ad will be displayed on screens larger than 992p
Mobile Banner (This ad will be displayed on screens smaller than 992px)
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Carver
Carver who carves the news
Post Details (Bottom)
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
